share_log

HC Wainwright & Co. Reiterates Buy on EFFECTOR Therapeutics, Maintains $24 Price Target

HC Wainwright & Co. Reiterates Buy on EFFECTOR Therapeutics, Maintains $24 Price Target

HC Wainwright & Co.重申买入EFFECTOR Therapeutics,维持24美元的目标股价
Moomoo 24/7 ·  03/28 06:12

HC Wainwright & Co. analyst Robert Burns reiterates eFFECTOR Therapeutics (NASDAQ:EFTR) with a Buy and maintains $24 price target.

HC Wainwright & Co. 分析师罗伯特·伯恩斯重申Effector Therapeutics(纳斯达克股票代码:EFTR)的买入并维持24美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发